104 related articles for article (PubMed ID: 10658594)
1. Synthesis and beta-lactamase inhibitory activity of new 6beta-cysteinesulfonamidopenicillanic acids.
Changov LS; Naydenova ED; Ivanova GI; Gergova RT; Keuleyan EE; Aleksiev BV
Bioorg Med Chem; 1999 Dec; 7(12):2899-904. PubMed ID: 10658594
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and beta-lactamase inhibitory activity of new 6 beta-sulfonamidopenicillanic acids.
Changov LS; Vassileva-Lukanova BK; Angelova-Galabova A; Pavlova AV; Spassov SL
Arzneimittelforschung; 1994 Jul; 44(7):856-8. PubMed ID: 7945522
[TBL] [Abstract][Full Text] [Related]
3. Methylene (2S,5R)-6-(3-formylallylidene)penicillanate pivalate, a prodrug of a new beta-lactamase inhibitor.
Adam S; Then R; Angehrn P
J Antibiot (Tokyo); 1992 Apr; 45(4):587-8. PubMed ID: 1317369
[No Abstract] [Full Text] [Related]
4. (6R,8S)-(2-benzimidazolyl)hydroxymethylpenicillanic acids as potent antibacterial agents and beta-lactamase inhibitors.
Chen YL; Hedberg K; Guarino K; Retsema JA; Anderson M; Manousos M; Barrett J
J Antibiot (Tokyo); 1991 Aug; 44(8):870-84. PubMed ID: 1655687
[TBL] [Abstract][Full Text] [Related]
5. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Nomura S; Hanaki H; Nagayama A
J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and beta-lactamase inhibitory activity of 6-fluoropenicillanic acids.
Danelon GO; Laborde M; Mascaretti OA; Boggio SB; Roveri OA
Bioorg Med Chem; 1993 Dec; 1(6):447-55. PubMed ID: 8087566
[TBL] [Abstract][Full Text] [Related]
7. Studies on penam sulfones. I. Synthesis and beta-lactamase inhibitory activity of 2 beta-alkoxycarbonyl penicillanic acid sulfones.
Setti EL; Reddy NA; Phillips OA; Czajkowski DP; Atchison K; Atwal H; Micetich RG; Maiti SN; Kunugita C; Hyodo A
J Antibiot (Tokyo); 1996 Sep; 49(9):944-6. PubMed ID: 8931732
[No Abstract] [Full Text] [Related]
8. Synthesis and evaluation of 2 beta-oxyimino and alkenylpenicillanic acid sulfone derivatives as beta-lactamase inhibitors.
Cho YS; Ha YJ; Kwon JS; Pae AN; Choi KI; Koh HY; Chang MH; Yoon CM; Lee GS
Arch Pharm (Weinheim); 1999 Jan; 332(1):7-12. PubMed ID: 10073138
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of new sulfonylamido-penicillanic acid sulfones inhibitors of beta-lactamases.
Vanwetswinkel S; Fastrez J; Marchand-Brynaert J
J Antibiot (Tokyo); 1994 Sep; 47(9):1041-51. PubMed ID: 7928692
[TBL] [Abstract][Full Text] [Related]
10. [A simple method of synthesis of S-sulfoxides of penicillanic acid and 6-alpha-bromo[chloro]-penicillanic acids].
Changov LS; Vasileva-Lukanova BK; Agapova NN; Tsenkova MM; Mondeshka DM; Ivanova ZT
Antibiot Khimioter; 1990 Aug; 35(8):12-3. PubMed ID: 2176073
[TBL] [Abstract][Full Text] [Related]
11. Chemical modification of tazobactam. Synthesis of 2 beta-[(4-substituted)-1,2,3-triazol-1-yl]methyl penicillanic acid sulfone derivatives.
Setti EL; Fiakpui C; Phillips OA; Czajkowski DP; Atchison K; Micetich RG; Maiti SN; Kunugita C; Hyodo A
J Antibiot (Tokyo); 1995 Nov; 48(11):1320-9. PubMed ID: 8557575
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of aminopenicillins combined with sulbactam, clavulanic acid, or amdinocillin against bacteria isolated from patients with complicated urinary tract infections.
Naber KG; Wittenberger R
Rev Infect Dis; 1986; 8 Suppl 5():S604-8. PubMed ID: 3026011
[TBL] [Abstract][Full Text] [Related]
13. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
Piddock LJ; Jin YF; Turner HL
J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
[TBL] [Abstract][Full Text] [Related]
14. [The effectiveness of so-called potentiated penicillins (augmentin and tazobactam) in vitro].
Blahová J; Hupková M; Krcméry V
Cas Lek Cesk; 1995 Sep; 134(17):558-61. PubMed ID: 7553760
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
Qadri SM; Ueno Y; Cunha BA
Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
[TBL] [Abstract][Full Text] [Related]
16. (6R)-6-(substituted methyl)penicillanic acid sulfones: new potent beta-lactamase inhibitors.
Adam S; Then R; Angehrn P
J Antibiot (Tokyo); 1993 Apr; 46(4):641-6. PubMed ID: 8388871
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of 6-bromo-6-substituted penicillanic acid derivatives as beta-lactamase inhibitors.
Bedini A; Balsamini C; Di Giacomo B; Tontini A; Citterio B; Giorgi L; Di Modugno E; Tarzia G
Farmaco; 2002 Aug; 57(8):663-9. PubMed ID: 12361234
[TBL] [Abstract][Full Text] [Related]
19. [Susceptibility of clinical strains of gram-positive bacteria to selected beta-lactam antibiotics].
Sawicka-Grzelak A; Rokosz A
Med Dosw Mikrobiol; 1998; 50(1-2):69-76. PubMed ID: 9857616
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of 6-(heterocyclyl)-methylene penam sulfones; a new class of beta-lactamase inhibitors.
Chen YL; Chang CW; Hedberg K; Guarino K; Welch WM; Kiessling L; Retsema JA; Haskell SL; Anderson M; Manousos M
J Antibiot (Tokyo); 1987 Jun; 40(6):803-22. PubMed ID: 3497142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
